Your browser doesn't support javascript.
loading
HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome.
Laberko, Alexandra; Burlakov, Vasiliy; Maier, Sarah; Abinun, Mario; Skinner, Roderick; Kozlova, Anna; Suri, Deepti; Lehmberg, Kai; Müller, Ingo; Balashov, Dmitry; Novichkova, Galina; Holzinger, Dirk; Gennery, Andrew R; Shcherbina, Anna.
Afiliação
  • Laberko A; Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. Electronic address: alexandra.laberko@gmail.com.
  • Burlakov V; Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Maier S; Division of Pediatric Stem Cell Transplantation and Immunology, Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany.
  • Abinun M; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; Great North Children's Hospital, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Skinner R; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; Great North Children's Hospital, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Kozlova A; Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Suri D; Great North Children's Hospital, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Lehmberg K; Division of Pediatric Stem Cell Transplantation and Immunology, Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany.
  • Müller I; Division of Pediatric Stem Cell Transplantation and Immunology, Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany.
  • Balashov D; Department of Hematopoietic Stem Cell Transplantation, Dmitry Rogachev National Medical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Novichkova G; Department of Hematology, Dmitry Rogachev National Medical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Holzinger D; Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany.
  • Gennery AR; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; Great North Children's Hospital, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Shcherbina A; Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
J Allergy Clin Immunol ; 148(1): 250-255.e1, 2021 07.
Article em En | MEDLINE | ID: mdl-33338535
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Mieloides / Proteínas do Citoesqueleto / Proteínas Adaptadoras de Transdução de Sinal / Doença Enxerto-Hospedeiro / Doenças Genéticas Inatas / Inflamação Tipo de estudo: Risk_factors_studies Limite: Child, preschool / Female / Humans / Male / Newborn Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Mieloides / Proteínas do Citoesqueleto / Proteínas Adaptadoras de Transdução de Sinal / Doença Enxerto-Hospedeiro / Doenças Genéticas Inatas / Inflamação Tipo de estudo: Risk_factors_studies Limite: Child, preschool / Female / Humans / Male / Newborn Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article